Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Lung Cancer

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 113 articles:
HTML format



Single Articles


    July 2022
  1. BIAN T, Wang Y, Botello JF, Hu Q, et al
    LKB1 phosphorylation and deactivation in lung cancer by NNAL, a metabolite of tobacco-specific carcinogen, in an isomer-dependent manner.
    Oncogene. 2022 Jul 14. pii: 10.1038/s41388-022-02410.
    PubMed     Abstract available


  2. THIRUSANGU P, Ray U, Sarkar Bhattacharya S, Oien DB, et al
    PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma.
    Oncogene. 2022 Jul 8. pii: 10.1038/s41388-022-02391.
    PubMed     Abstract available


  3. ALFARO-ARNEDO E, Lopez IP, Pineiro-Hermida S, Canalejo M, et al
    IGF1R acts as a cancer-promoting factor in the tumor microenvironment facilitating lung metastasis implantation and progression.
    Oncogene. 2022;41:3625-3639.
    PubMed     Abstract available


  4. ZENG Z, Xu S, Wang F, Peng X, et al
    HAO1-mediated oxalate metabolism promotes lung pre-metastatic niche formation by inducing neutrophil extracellular traps.
    Oncogene. 2022;41:3719-3731.
    PubMed     Abstract available


    June 2022
  5. GALLARDO A, Molina A, Asenjo HG, Lopez-Onieva L, et al
    EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization.
    Oncogene. 2022 Jun 9. pii: 10.1038/s41388-022-02375.
    PubMed     Abstract available


  6. UESHIMA S, Fang J
    Histone H3K9 methyltransferase SETDB1 augments invadopodia formation to promote tumor metastasis.
    Oncogene. 2022;41:3370-3380.
    PubMed     Abstract available


    May 2022
  7. HAMAD SH, Montgomery SA, Simon JM, Bowman BM, et al
    TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice.
    Oncogene. 2022 May 16. pii: 10.1038/s41388-022-02348.
    PubMed     Abstract available


  8. LU X, Wang J, Wang W, Lu C, et al
    Copy number amplification and SP1-activated lncRNA MELTF-AS1 regulates tumorigenesis by driving phase separation of YBX1 to activate ANXA8 in non-small cell lung cancer.
    Oncogene. 2022 May 4. pii: 10.1038/s41388-022-02292.
    PubMed     Abstract available


  9. LI X, Chen H, Zhang L, Chen L, et al
    27-hydroxycholesterol linked high cholesterol diet to lung adenocarcinoma metastasis.
    Oncogene. 2022;41:2685-2695.
    PubMed     Abstract available


    April 2022
  10. LIU Y, Luo Y, Yan S, Lian YF, et al
    CRL2(KLHDC3) mediates p14ARF N-terminal ubiquitylation degradation to promote non-small cell lung carcinoma progression.
    Oncogene. 2022 Apr 25. pii: 10.1038/s41388-022-02318.
    PubMed     Abstract available


  11. TYAGI A, Wu SY, Sharma S, Wu K, et al
    Exosomal miR-4466 from nicotine-activated neutrophils promotes tumor cell stemness and metabolism in lung cancer metastasis.
    Oncogene. 2022 Apr 23. pii: 10.1038/s41388-022-02322.
    PubMed     Abstract available


  12. BAUMER N, Tiemann J, Scheller A, Meyer T, et al
    Targeted siRNA nanocarrier: a platform technology for cancer treatment.
    Oncogene. 2022;41:2210-2224.
    PubMed     Abstract available


  13. IKEUCHI H, Hirose T, Ikegami M, Takamochi K, et al
    Preclinical assessment of combination therapy of EGFR tyrosine kinase inhibitors in a highly heterogeneous tumor model.
    Oncogene. 2022;41:2470-2479.
    PubMed     Abstract available


    March 2022
  14. WANG C, Zhang S, Ma B, Fu Y, et al
    TP53 mutations upregulate RCP expression via Sp1/3 to drive lung cancer progression.
    Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02260.
    PubMed     Abstract available


  15. WU WR, Shi XD, Zhang FP, Zhu K, et al
    Activation of the Notch1-c-myc-VCAM1 signalling axis initiates liver progenitor cell-driven hepatocarcinogenesis and pulmonary metastasis.
    Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02246.
    PubMed     Abstract available


  16. MA G, Deng Y, Qian L, Vallega KA, et al
    Overcoming acquired resistance to third-generation EGFR inhibitors by targeting activation of intrinsic apoptotic pathway through Mcl-1 inhibition, Bax activation, or both.
    Oncogene. 2022;41:1691-1700.
    PubMed     Abstract available


  17. JEONG HS, Lee DH, Kim SH, Lee CH, et al
    Hyperglycemia-induced oxidative stress promotes tumor metastasis by upregulating vWF expression in endothelial cells through the transcription factor GATA1.
    Oncogene. 2022;41:1634-1646.
    PubMed     Abstract available


  18. HONG SY, Lu YC, Hsiao SH, Kao YR, et al
    Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma.
    Oncogene. 2022;41:1907-1917.
    PubMed     Abstract available


    February 2022
  19. TSUBOYAMA N, Wang R, Szczepanski AP, Chen H, et al
    Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer.
    Oncogene. 2022 Feb 22. pii: 10.1038/s41388-022-02240.
    PubMed     Abstract available


  20. LIAO CG, Liang XH, Ke Y, Yao L, et al
    Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis.
    Oncogene. 2022 Feb 7. pii: 10.1038/s41388-022-02213.
    PubMed     Abstract available


  21. JIN Y, Pan Y, Zheng S, Liu Y, et al
    Inactivation of EGLN3 hydroxylase facilitates Erk3 degradation via autophagy and impedes lung cancer growth.
    Oncogene. 2022 Feb 5. pii: 10.1038/s41388-022-02203.
    PubMed     Abstract available


  22. CHO HC, Huang Y, Hung JT, Hung TH, et al
    Puf-A promotes cancer progression by interacting with nucleophosmin in nucleolus.
    Oncogene. 2022;41:1155-1165.
    PubMed     Abstract available


    January 2022
  23. MEINHARDT AL, Munkhbaatar E, Hockendorf U, Dietzen M, et al
    The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner.
    Oncogene. 2022 Jan 29. pii: 10.1038/s41388-021-02161.
    PubMed     Abstract available


  24. JIN X, Zhang B, Zhang H, Yu H, et al
    Smoking-associated upregulation of CBX3 suppresses ARHGAP24 expression to activate Rac1 signaling and promote tumor progression in lung adenocarcinoma.
    Oncogene. 2022;41:538-549.
    PubMed     Abstract available


  25. ALAM SK, Zhang Y, Wang L, Zhu Z, et al
    DARPP-32 promotes ERBB3-mediated resistance to molecular targeted therapy in EGFR-mutated lung adenocarcinoma.
    Oncogene. 2022;41:83-98.
    PubMed     Abstract available


    December 2021
  26. ALHAYYANI S, McLeod L, West AC, Balic JJ, et al
    Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer.
    Oncogene. 2021 Dec 3. pii: 10.1038/s41388-021-02134.
    PubMed     Abstract available


  27. BISCHOFF P, Trinks A, Obermayer B, Pett JP, et al
    Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma.
    Oncogene. 2021;40:6748-6758.
    PubMed     Abstract available


  28. LIU R, Gou D, Xiang J, Pan X, et al
    O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis.
    Oncogene. 2021;40:6707-6719.
    PubMed     Abstract available


  29. CHEN Z, Yu D, Owonikoko TK, Ramalingam SS, et al
    Induction of SREBP1 degradation coupled with suppression of SREBP1-mediated lipogenesis impacts the response of EGFR mutant NSCLC cells to osimertinib.
    Oncogene. 2021;40:6653-6665.
    PubMed     Abstract available


    November 2021
  30. SHIN DH, Kim SH, Choi M, Bae YK, et al
    Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1.
    Oncogene. 2021 Nov 6. pii: 10.1038/s41388-021-02097.
    PubMed     Abstract available


  31. LI M, Li X, Goldsmith JR, Shi S, et al
    Decoupling tumor cell metastasis from growth by cellular pilot protein TNFAIP8.
    Oncogene. 2021;40:6456-6468.
    PubMed     Abstract available


  32. ROUKENS MG, Frederiks CL, Seinstra D, Braccioli L, et al
    Regulation of a progenitor gene program by SOX4 is essential for mammary tumor proliferation.
    Oncogene. 2021;40:6343-6353.
    PubMed     Abstract available


    October 2021
  33. INGRAM K, Samson SC, Zewdu R, Zitnay RG, et al
    NKX2-1 controls lung cancer progression by inducing DUSP6 to dampen ERK activity.
    Oncogene. 2021 Oct 23. pii: 10.1038/s41388-021-02076.
    PubMed     Abstract available


  34. CHEN J, Guanizo A, Luong Q, Jayasekara WSN, et al
    Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium.
    Oncogene. 2021 Oct 21. pii: 10.1038/s41388-021-02070.
    PubMed     Abstract available


  35. LIANG SK, Hsu CC, Song HL, Huang YC, et al
    Correction: FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.
    Oncogene. 2021 Oct 12. pii: 10.1038/s41388-021-02044.
    PubMed    


    September 2021
  36. TAKAGI S, Sasaki Y, Koike S, Takemoto A, et al
    Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis.
    Oncogene. 2021;40:5548-5558.
    PubMed     Abstract available


  37. XU G, Yang Z, Ding Y, Liu Y, et al
    The deubiquitinase USP16 functions as an oncogenic factor in K-RAS-driven lung tumorigenesis.
    Oncogene. 2021;40:5482-5494.
    PubMed     Abstract available


    August 2021
  38. LEONARD MK, Puts GS, Pamidimukkala N, Adhikary G, et al
    Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients.
    Oncogene. 2021 Aug 25. pii: 10.1038/s41388-021-01998.
    PubMed     Abstract available


  39. MELOCCHI V, Dama E, Mazzarelli F, Cuttano R, et al
    Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype.
    Oncogene. 2021;40:4980-4991.
    PubMed     Abstract available


    July 2021
  40. CHEN CH, Wang BW, Hsiao YC, Wu CY, et al
    PKCdelta-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs.
    Oncogene. 2021;40:4796-4808.
    PubMed     Abstract available


  41. WU J, Li L, Zhang H, Zhao Y, et al
    A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma.
    Oncogene. 2021;40:4413-4424.
    PubMed     Abstract available


    June 2021
  42. LIANG SK, Hsu CC, Song HL, Huang YC, et al
    FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.
    Oncogene. 2021 Jun 21. pii: 10.1038/s41388-021-01895.
    PubMed     Abstract available


  43. LIU W, Huang Y, Wang D, Han F, et al
    MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway.
    Oncogene. 2021 Jun 9. pii: 10.1038/s41388-021-01857.
    PubMed     Abstract available


  44. YANG X, Chen Y, Zhou Y, Wu C, et al
    GPC5 suppresses lung cancer progression and metastasis via intracellular CTDSP1/AhR/ARNT signaling axis and extracellular exosome secretion.
    Oncogene. 2021 Jun 2. pii: 10.1038/s41388-021-01837.
    PubMed     Abstract available


  45. LI M, Shi M, Hu C, Chen B, et al
    MALAT1 modulated FOXP3 ubiquitination then affected GINS1 transcription and drived NSCLC proliferation.
    Oncogene. 2021;40:3870-3884.
    PubMed     Abstract available


    May 2021
  46. XU Q, Zhang J, Telfer BA, Zhang H, et al
    The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion.
    Oncogene. 2021 May 12. pii: 10.1038/s41388-021-01798.
    PubMed     Abstract available


  47. VENUGOPALAN A, Lynberg M, Cultraro CM, Nguyen KDP, et al
    SCAMP3 is a mutant EGFR phosphorylation target and a tumor suppressor in lung adenocarcinoma.
    Oncogene. 2021;40:3331-3346.
    PubMed     Abstract available


  48. RANGEL DF, Dubeau L, Park R, Chan P, et al
    Endoplasmic reticulum chaperone GRP78/BiP is critical for mutant Kras-driven lung tumorigenesis.
    Oncogene. 2021;40:3624-3632.
    PubMed     Abstract available


  49. ZHANG Q, Tang Q, Liu W, Hu C, et al
    Novel role of CAP1 in regulation RNA polymerase II-mediated transcription elongation depends on its actin-depolymerization activity in nucleoplasm.
    Oncogene. 2021;40:3492-3509.
    PubMed     Abstract available


  50. WU S, Liu B, Zhang Y, Hong R, et al
    Long non-coding RNA LEISA promotes progression of lung adenocarcinoma via enhancing interaction between STAT3 and IL-6 promoter.
    Oncogene. 2021;40:3449-3459.
    PubMed     Abstract available


    April 2021
  51. XU L, Liu W, Li T, Hu Y, et al
    Long non-coding RNA SMASR inhibits the EMT by negatively regulating TGF-beta/Smad signaling pathway in lung cancer.
    Oncogene. 2021 Apr 30. pii: 10.1038/s41388-021-01760.
    PubMed     Abstract available


  52. ALI MM, Di Marco M, Mahale S, Jachimowicz D, et al
    LY6K-AS lncRNA is a lung adenocarcinoma prognostic biomarker and regulator of mitotic progression.
    Oncogene. 2021;40:2463-2478.
    PubMed     Abstract available


  53. PAN Y, Han H, Labbe KE, Zhang H, et al
    Recent advances in preclinical models for lung squamous cell carcinoma.
    Oncogene. 2021;40:2817-2829.
    PubMed     Abstract available


    March 2021
  54. MORENO T, Monterde B, Gonzalez-Silva L, Betancor-Fernandez I, et al
    ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01748.
    PubMed     Abstract available


  55. CHENG C, Pei X, Li SW, Yang J, et al
    CRISPR/Cas9 library screening uncovered methylated PKP2 as a critical driver of lung cancer radioresistance by stabilizing beta-catenin.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01692.
    PubMed     Abstract available


  56. MA S, Zhang L, Ren Y, Dai W, et al
    Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer.
    Oncogene. 2021 Mar 9. pii: 10.1038/s41388-021-01734.
    PubMed     Abstract available


  57. MENG C, Zhan J, Chen D, Shao G, et al
    The deubiquitinase USP11 regulates cell proliferation and ferroptotic cell death via stabilization of NRF2 USP11 deubiquitinates and stabilizes NRF2.
    Oncogene. 2021;40:1706-1720.
    PubMed     Abstract available


  58. TURGU B, Zhang F, El-Naggar A, Negri GL, et al
    HACE1 blocks HIF1alpha accumulation under hypoxia in a RAC1 dependent manner.
    Oncogene. 2021;40:1988-2001.
    PubMed     Abstract available


  59. CHEN L, Zhang Y, Shu X, Chen Q, et al
    Proteasome regulation by reversible tyrosine phosphorylation at the membrane.
    Oncogene. 2021;40:1942-1956.
    PubMed     Abstract available


  60. GUO Z, Dai Y, Hu W, Zhang Y, et al
    The long noncoding RNA CRYBG3 induces aneuploidy by interfering with spindle assembly checkpoint via direct binding with Bub3.
    Oncogene. 2021;40:1821-1835.
    PubMed     Abstract available


    February 2021
  61. WU R, Li K, Yuan M, Luo KQ, et al
    Nerve growth factor receptor increases the tumor growth and metastatic potential of triple-negative breast cancer cells.
    Oncogene. 2021 Feb 24. pii: 10.1038/s41388-021-01691.
    PubMed     Abstract available


  62. KWON OS, Lee H, Kong HJ, Kwon EJ, et al
    Correction to: Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer.
    Oncogene. 2021 Feb 11. pii: 10.1038/s41388-021-01642.
    PubMed    


  63. ZHAO L, Wu X, Zheng J, Dong D, et al
    DNA methylome profiling of circulating tumor cells in lung cancer at single base-pair resolution.
    Oncogene. 2021 Feb 9. pii: 10.1038/s41388-021-01657.
    PubMed     Abstract available


  64. LIU PI, Chang AC, Lai JL, Lin TH, et al
    Melatonin interrupts osteoclast functioning and suppresses tumor-secreted RANKL expression: implications for bone metastases.
    Oncogene. 2021;40:1503-1515.
    PubMed     Abstract available


  65. CHENG FJ, Chen CH, Tsai WC, Wang BW, et al
    Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC.
    Oncogene. 2021;40:1162-1175.
    PubMed     Abstract available


    January 2021
  66. LIN S, Zhang X, Huang G, Cheng L, et al
    Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cells.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01605.
    PubMed     Abstract available


  67. GAROFALO M, Quintavalle C, Di Leva G, Zanca C, et al
    Correction: MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer.
    Oncogene. 2021 Jan 4. pii: 10.1038/s41388-020-01608.
    PubMed    


  68. ALSAFADI S, Dayot S, Tarin M, Houy A, et al
    Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers.
    Oncogene. 2021;40:85-96.
    PubMed     Abstract available


  69. HE D, Wang D, Lu P, Yang N, et al
    Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations.
    Oncogene. 2021;40:355-368.
    PubMed     Abstract available


  70. TANG L, Xiong W, Zhang L, Wang D, et al
    circSETD3 regulates MAPRE1 through miR-615-5p and miR-1538 sponges to promote migration and invasion in nasopharyngeal carcinoma.
    Oncogene. 2021;40:307-321.
    PubMed     Abstract available


  71. LIU X, Wang F, Xu C, Chen X, et al
    Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma.
    Oncogene. 2021;40:821-832.
    PubMed     Abstract available


  72. LIN WH, Chang YW, Hong MX, Hsu TC, et al
    STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis.
    Oncogene. 2021;40:791-805.
    PubMed     Abstract available


  73. GUHA P, Gardell J, Rabinowitz B, Lopes M, et al
    Monocytic and granulocytic myeloid-derived suppressor cell plasticity and differentiation are organ-specific.
    Oncogene. 2021;40:693-704.
    PubMed     Abstract available


    December 2020
  74. CUI C, Liu Y, Gerloff D, Rohde C, et al
    NOP10 predicts lung cancer prognosis and its associated small nucleolar RNAs drive proliferation and migration.
    Oncogene. 2020 Dec 7. pii: 10.1038/s41388-020-01570.
    PubMed     Abstract available


    November 2020
  75. LIU Y, Wang X, Li W, Xu Y, et al
    Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1alpha mediated XPC transcription.
    Oncogene. 2020;39:6893-6905.
    PubMed     Abstract available


    October 2020
  76. NIMMAKAYALA RK, Leon F, Rachagani S, Rauth S, et al
    Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01518.
    PubMed     Abstract available


  77. TUMBRINK HL, Heimsoeth A, Sos ML
    The next tier of EGFR resistance mutations in lung cancer.
    Oncogene. 2020 Oct 15. pii: 10.1038/s41388-020-01510.
    PubMed     Abstract available


  78. SHEN H, Wang GC, Li X, Ge X, et al
    S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer.
    Oncogene. 2020 Oct 9. pii: 10.1038/s41388-020-01497.
    PubMed     Abstract available


  79. OCHIENG JK, Kundu ST, Bajaj R, Leticia Rodriguez B, et al
    MBIP (MAP3K12 binding inhibitory protein) drives NSCLC metastasis by JNK-dependent activation of MMPs.
    Oncogene. 2020;39:6719-6732.
    PubMed     Abstract available


  80. LENG X, Wang J, An N, Wang X, et al
    Histone 3 lysine-27 demethylase KDM6A coordinates with KMT2B to play an oncogenic role in NSCLC by regulating H3K4me3.
    Oncogene. 2020;39:6468-6479.
    PubMed     Abstract available


    September 2020
  81. JESSEN C, Kress JKC, Baluapuri A, Hufnagel A, et al
    The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression.
    Oncogene. 2020 Sep 25. pii: 10.1038/s41388-020-01477.
    PubMed     Abstract available


  82. WANG K, Ji W, Yu Y, Li Z, et al
    Correction: FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer.
    Oncogene. 2020 Sep 7. pii: 10.1038/s41388-020-01441.
    PubMed     Abstract available


  83. BAJAJ R, Kundu ST, Grzeskowiak CL, Fradette JJ, et al
    IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion.
    Oncogene. 2020;39:5979-5994.
    PubMed     Abstract available


    August 2020
  84. ZHANG X, Li F, Tang Y, Ren Q, et al
    miR-21a in exosomes from Lewis lung carcinoma cells accelerates tumor growth through targeting PDCD4 to enhance expansion of myeloid-derived suppressor cells.
    Oncogene. 2020 Aug 27. pii: 10.1038/s41388-020-01406.
    PubMed     Abstract available


  85. LI C, Zhao W, Pan X, Li X, et al
    LncRNA KTN1-AS1 promotes the progression of non-small cell lung cancer via sponging of miR-130a-5p and activation of PDPK1.
    Oncogene. 2020 Aug 20. pii: 10.1038/s41388-020-01427.
    PubMed     Abstract available


  86. ZHU Y, Li J, Bo H, He D, et al
    LINC00467 is up-regulated by TDG-mediated acetylation in non-small cell lung cancer and promotes tumor progression.
    Oncogene. 2020 Aug 14. pii: 10.1038/s41388-020-01421.
    PubMed     Abstract available


  87. WANG M, Long K, Li E, Li L, et al
    DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation.
    Oncogene. 2020;39:5507-5519.
    PubMed     Abstract available


    July 2020
  88. ROH JI, Lee J, Sung YH, Oh J, et al
    Impaired AKT signaling and lung tumorigenesis by PIERCE1 ablation in KRAS-mutant non-small cell lung cancer.
    Oncogene. 2020 Jul 29. pii: 10.1038/s41388-020-01399.
    PubMed     Abstract available


  89. MENG DF, Sun R, Liu GY, Peng LX, et al
    S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1.
    Oncogene. 2020;39:5307-5322.
    PubMed     Abstract available


  90. HYSLOP SR, Alexander M, Thai AA, Kersbergen A, et al
    Targeting platelets for improved outcome in KRAS-driven lung adenocarcinoma.
    Oncogene. 2020;39:5177-5186.
    PubMed     Abstract available


    June 2020
  91. ZHANG X, Yang L, Szeto P, Abali GK, et al
    The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis.
    Oncogene. 2020 Jun 19. pii: 10.1038/s41388-020-1362.
    PubMed     Abstract available


  92. KOYEN AE, Madden MZ, Park D, Minten EV, et al
    EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair.
    Oncogene. 2020;39:4798-4813.
    PubMed     Abstract available


    May 2020
  93. KWON OS, Lee H, Kong HJ, Kwon EJ, et al
    Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer.
    Oncogene. 2020 May 9. pii: 10.1038/s41388-020-1316.
    PubMed     Abstract available


  94. HSIEN LAI S, Zervoudakis G, Chou J, Gurney ME, et al
    PDE4 subtypes in cancer.
    Oncogene. 2020;39:3791-3802.
    PubMed     Abstract available


  95. YU L, Dong L, Li H, Liu Z, et al
    Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis.
    Oncogene. 2020;39:4450-4464.
    PubMed     Abstract available


    April 2020
  96. TIAN Q, Yuan P, Quan C, Li M, et al
    Phosphorylation of BCKDK of BCAA catabolism at Y246 by Src promotes metastasis of colorectal cancer.
    Oncogene. 2020 Apr 1. pii: 10.1038/s41388-020-1262.
    PubMed     Abstract available


  97. LI F, Li Z, Han Q, Cheng Y, et al
    Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104.
    Oncogene. 2020;39:3507-3521.
    PubMed     Abstract available


  98. LI Y, Zhang H, Fan L, Mou J, et al
    MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeability.
    Oncogene. 2020;39:3473-3488.
    PubMed     Abstract available


  99. KASIRI S, Chen B, Wilson AN, Reczek A, et al
    Stromal Hedgehog pathway activation by IHH suppresses lung adenocarcinoma growth and metastasis by limiting reactive oxygen species.
    Oncogene. 2020;39:3258-3275.
    PubMed     Abstract available


  100. YIN H, Jiang Z, Feng X, Ji Z, et al
    Identification of Sca-1(+)Abcg1(+) bronchioalveolar epithelial cells as the origin of lung adenocarcinoma in Gprc5a-knockout mouse model through the interaction between lung progenitor AT2 and Lgr5 cells.
    Oncogene. 2020;39:3754-3773.
    PubMed     Abstract available


  101. WANG T, Jing B, Xu D, Liao Y, et al
    PTGES/PGE2 signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model.
    Oncogene. 2020;39:3179-3194.
    PubMed     Abstract available


    March 2020
  102. WANG Y, Ma R, Liu B, Kong J, et al
    SNP rs17079281 decreases lung cancer risk through creating an YY1-binding site to suppress DCBLD1 expression.
    Oncogene. 2020 Mar 30. pii: 10.1038/s41388-020-1278.
    PubMed     Abstract available


  103. YANG W, Khoury E, Guo Q, Prabhu SA, et al
    MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression.
    Oncogene. 2020 Mar 4. pii: 10.1038/s41388-020-1240.
    PubMed     Abstract available


  104. CHAN YC, Chang YC, Chuang HH, Yang YC, et al
    Overexpression of PSAT1 promotes metastasis of lung adenocarcinoma by suppressing the IRF1-IFNgamma axis.
    Oncogene. 2020;39:2509-2522.
    PubMed     Abstract available


    February 2020
  105. HUANG J, Lan X, Wang T, Lu H, et al
    Targeting the IL-1beta/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC.
    Oncogene. 2020;39:1739-1755.
    PubMed     Abstract available


  106. ZHANG Q, Fan H, Liu H, Jin J, et al
    WNT5B exerts oncogenic effects and is negatively regulated by miR-5587-3p in lung adenocarcinoma progression.
    Oncogene. 2020;39:1484-1497.
    PubMed     Abstract available


    January 2020
  107. ZHANG J, Lin X, Wu L, Huang JJ, et al
    Aurora B induces epithelial-mesenchymal transition by stabilizing Snail1 to promote basal-like breast cancer metastasis.
    Oncogene. 2020 Jan 29. pii: 10.1038/s41388-020-1165.
    PubMed     Abstract available


  108. WU X, Zhang X, Yu L, Zhang C, et al
    Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer.
    Oncogene. 2020 Jan 27. pii: 10.1038/s41388-020-1166.
    PubMed     Abstract available


  109. DIAS MM, Adamoski D, Dos Reis LM, Ascencao CFR, et al
    GLS2 is protumorigenic in breast cancers.
    Oncogene. 2020;39:690-702.
    PubMed     Abstract available


  110. SMEESTER BA, Slipek NJ, Pomeroy EJ, Bomberger HE, et al
    SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis.
    Oncogene. 2020;39:1049-1062.
    PubMed     Abstract available


  111. WANG D, Cheng X, Li Y, Guo M, et al
    C/EBPdelta-Slug-Lox1 axis promotes metastasis of lung adenocarcinoma via oxLDL uptake.
    Oncogene. 2020;39:833-848.
    PubMed     Abstract available


    December 2019
  112. FANG R, Xu F, Shi H, Wu Y, et al
    LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity.
    Oncogene. 2019 Dec 13. pii: 10.1038/s41388-019-1146.
    PubMed     Abstract available


    October 2019
  113. ZHANGYUAN G, Wang F, Zhang H, Jiang R, et al
    VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.
    Oncogene. 2019 Oct 11. pii: 10.1038/s41388-019-1052.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: